This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
home:physicians:concerns [06.05.2019] – [Concerns about lack of clinical evidence] sallieq | home:physicians:concerns [07.13.2019] – [Concerns about immunopathology] sallieq | ||
---|---|---|---|
Line 7: | Line 7: | ||
===== Concerns about lack of clinical evidence ===== | ===== Concerns about lack of clinical evidence ===== | ||
- | - **" | + | - **" |
* a [[home: | * a [[home: | ||
* a [[home: | * a [[home: | ||
Line 17: | Line 17: | ||
For some physicians, the above evidence is not sufficiently compelling to warrant automatically starting a patient on the MP without further consideration. Here are some other factors which may play a role in the clinical judgment: | For some physicians, the above evidence is not sufficiently compelling to warrant automatically starting a patient on the MP without further consideration. Here are some other factors which may play a role in the clinical judgment: | ||
- | * evidence | + | * alternative hypotheses and evidence of research |
- | * 2013 material | + | * evidence for the efficacy of MP versus other available treatment in 2013 data on patient response, see section below |
* patients' | * patients' | ||
* additional benefits of Olmesartan [[https:// | * additional benefits of Olmesartan [[https:// | ||
Line 27: | Line 27: | ||
< | < | ||
- | ===== Recorded | + | ==== Recorded |
< | < | ||
Line 81: | Line 81: | ||
- **"A temporary increase in symptoms or laboratory values means the treatment is not working." | - **"A temporary increase in symptoms or laboratory values means the treatment is not working." | ||
+ | |||
+ | see also [[home: | ||
===== Concerns about antibiotics===== | ===== Concerns about antibiotics===== | ||
Line 117: | Line 119: | ||
{{tag> | {{tag> | ||
- | [[home: | + | [[home: |
===== Notes and comments ===== | ===== Notes and comments ===== | ||